Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years
近年来,儿童再生障碍性贫血患者接受造血干细胞移植(HSCT)治疗,无论是否先进行免疫抑制治疗(IST),其疗效均相当。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025018285
Andresen, Felicia; Yoshimi, Ayami; Bader, Peter; Bierings, Marc; Bod'ová, Ivana; Bordon, Victoria; Buechner, Jochen; Burkhardt, Birgit; Dworzak, Michael; Erlacher, Miriam; Kállay, Krisztián; Labarque, Veerle; Locatelli, Franco; Malone, Andrea; Masmas, Tania; Müller, Ingo; Nöllke, Peter; Schmugge, Markus; Pawelec, Katarzyna; Sedlacek, Petr; Sevilla, Julian; Smith, Owen; Stary, Jan; Niemeyer, Charlotte; Strahm, Brigitte
发育与干细胞
HTRF
代谢
干细胞
细胞生物学
贫血
免疫/内分泌